CAPRE
Dead / Cancelled — Cancelled — Section 8 (as of 24 Oct 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87812220
- Registration number
- 5719474
- Mark type
- Stylized text
- Filed
- 27 Feb 2018
- Published for opposition
- 22 Jan 2019
- Registered
- 09 Apr 2019
- Attorney of record
- James R Menker
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for lowering LDL-cholesterol and triglycerides, for increasing HDL and regulating glucose intolerance
Owner
- AKER BIOMARINE HUMAN INGREDIENTS AS, LYSAKER, NO
- Acasti Pharma Inc., Laval, QC, CA
- Acasti Pharma Inc., Laval, QC, CA
- Acasti Pharma Inc., Laval, QC, CA
Prosecution history
- 24 Oct 2025 — CANCELLED SEC. 8 (6-YR)
- 24 Feb 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 09 Apr 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 09 Apr 2019 — REGISTERED-PRINCIPAL REGISTER
- 22 Jan 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Jan 2019 — PUBLISHED FOR OPPOSITION
- 02 Jan 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Dec 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Dec 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Dec 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Dec 2018 — ASSIGNED TO LIE
- 02 Dec 2018 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 15 Jun 2018 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 15 Jun 2018 — LETTER OF SUSPENSION E-MAILED
- 15 Jun 2018 — SUSPENSION LETTER WRITTEN